ÂÜÀòÂÒÂ×

Dr. Lin has demonstrated a track record of strong leadership and scientific expertise in drug metabolism, pharmacokinetics and clinical pharmacology in drug discovery and development. Her extensive experience includes PKPD and PBPK modelling to bridge drug metabolism and preclinical safety results into clinical study design. Dr. Lin also brings an experience and leadership in regulatory filing from IND to NDA. Prior to Regor, she has worked in AbbVie, Pfizer, and Sunovion/Sumitomo in the discipline of preclinical research and clinical pharmacology for over 20 years. Dr. Lin received her B.S. in chemistry from East China Normal University, and PhD in organic chemistry from Loyola University of Chicago. She was a postdoctoral fellow in University of Washington in the field of drug metabolism. Dr. Lin has authored >30 publications and meeting presentations.